Fibroblast growth factor 9 (FGF9) regulation of cyclin D1 and cyclin-dependent kinase-4 in ovarian granulosa and theca cells of cattle.
To determine the mechanism by which fibroblast growth factor 9 (FGF9) alters granulosa (GC) and theca (TC) cell proliferation, cell cycle proteins that regulate progression through G1 phase of the cell cycle, cyclin D1 (CCND1) and cyclin-dependent kinase-4 (CDK4; CCND1's catalytic partner), were evaluated. Ovaries were obtained from a local abattoir, GC were harvested from small (1-5 mm) and large (8-22 mm) follicles, and TC were harvested from large follicles. GC and TC were plated in medium containing 10% fetal calf serum followed by various treatments in serum-free medium. Treatment with 30 ng/mL of either FGF9 or IGF1 significantly increased GC numbers and when combined, synergized to further increase GC numbers by threefold. Abundance of CCND1 and CDK4 mRNA in TC and GC were quantified via real-time PCR. Alone and in combination with IGF1, FGF9 significantly increased CCND1 mRNA expression in both GC and TC. Western blotting revealed that CCND1 protein levels were increased by FGF9 in TC after 6 h and 12 h of treatment, but CDK4 protein was not affected. A mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway inhibitor, U0126, significantly reduced FGF9-induced CCND1 mRNA expression to basal levels. For the first time we show that CCND1 mRNA expression is increased by FGF9 in bovine TC and GC, and that FGF9 likely uses the MAPK pathway to induce CCND1 mRNA production in bovine TC.
Department of Animal Science, Oklahoma State University, Stillwater, OK, 74078, USA.
M L
ML
Totty
Department of Animal Science, Oklahoma State University, Stillwater, OK, 74078, USA.
B C
BC
Morrell
Department of Animal Science, Oklahoma State University, Stillwater, OK, 74078, USA. Electronic address: leon.spicer@okstate.edu.
L J
LJ
Spicer
D000818:Animals; D002070:Butadienes / Q000494:pharmacology; D002417:Cattle; D049109:Cell Proliferation / Q000187:drug effects; D019938:Cyclin D1 / Q000235:genetics / Q000378:metabolism*; D051358:Cyclin-Dependent Kinase 4 / Q000378:metabolism*; D005260:Female; D051525:Fibroblast Growth Factor 9 / Q000494:pharmacology*; D005640:Follicle Stimulating Hormone / Q000494:pharmacology; D006107:Granulosa Cells / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology; D009570:Nitriles / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012756:Sheep; D013799:Theca Cells / Q000187:drug effects / Q000378:metabolism*
D002070:Butadienes; D051525:Fibroblast Growth Factor 9; D009570:Nitriles; D012333:RNA, Messenger; C113580:U 0126; D019938:Cyclin D1; D007334:Insulin-Like Growth Factor I; D005640:Follicle Stimulating Hormone; D051358:Cyclin-Dependent Kinase 4
Cattle; Cyclin D1 (CCND1); Cyclin-dependent kinase 4 (CDK4); Fibroblast growth factor 9 (FGF9); Granulosa cells; Theca cells